OAR Continues to Advocate for Non-medical Switching Reform
posted: December 2, 2020
House Bill 418 provides increased patient protections by placing restrictions on insurers and pharmacy benefit managers by prohibiting removal of a drug from a formulary or increasing cost-sharing and tier switches for a drug during a plan year. HB418 was favorably passed out of committee in early December. Advocates will push for a vote by the full House before the end of the year, in the hope of generating momentum for swift and favorable consideration in 2021.
To support this effort, we are looking to hear from providers and patients who have been impacted by non-medical switching practices to share their experiences. Your testimony will bring greater awareness to the negative impact forced medication switches have on patients.
Please contact OAR via email or Twitter to share your non-medical switching stories and help us in this effort.